October 17, 2016 / 11:32 AM / 10 months ago

BRIEF-Shire announces update to vyvanse U.S. labeling

Oct 17 (Reuters) - Shire PLC

* Shire PLC - Shire announces update to vyvanse (lisdexamfetamine dimesylate) U.S. labeling

* Shire PLC - labeling to include information regarding approval of a supplemental new drug application (SNDA) by U.S. Food and Drug Administration

* Shire PLC - labeling will now include maintenance of efficacy data from SPD489-346 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below